Ethane;bis(1H-indazole);tetrakis(2-methylpropane);bis(piperidine);2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;1-propan-2-ylbenzotriazole;2-propan-2-ylbenzotriazole;2-propan-2-yl-1,3-benzoxazole
C122H232N16OS — CID 158436560
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethane;bis(1H-indazole);tetrakis(2-methylpropane);bis(piperidine);2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;1-propan-2-ylbenzotriazole;2-propan-2-ylbenzotriazole;2-propan-2-yl-1,3-benzoxazole
Ethane;bis(1H-indazole);tetrakis(2-methylpropane);bis(piperidine);2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;1-propan-2-ylbenzotriazole;2-propan-2-ylbenzotriazole;2-propan-2-yl-1,3-benzoxazole (PubChem CID 158436560) has the molecular formula C122H232N16OS and a molecular weight of 1971.38 g/mol. Its IUPAC name is ethane;bis(1H-indazole);tetrakis(2-methylpropane);bis(piperidine);2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;1-propan-2-ylbenzotriazole;2-propan-2-ylbenzotriazole;2-propan-2-yl-1,3-benzoxazole.
Molecular Properties
| Compound Name | Ethane;bis(1H-indazole);tetrakis(2-methylpropane);bis(piperidine);2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;1-propan-2-ylbenzotriazole;2-propan-2-ylbenzotriazole;2-propan-2-yl-1,3-benzoxazole |
|---|---|
| PubChem CID | 158436560 |
| Molecular Formula | C122H232N16OS |
| Molecular Weight | 1971.38 g/mol |
| Exact Mass | 1969.83 |
| IUPAC Name | ethane;bis(1H-indazole);tetrakis(2-methylpropane);bis(piperidine);2-propan-2-yl-1H-benzimidazole;2-propan-2-yl-1,3-benzothiazole;1-propan-2-ylbenzotriazole;2-propan-2-ylbenzotriazole;2-propan-2-yl-1,3-benzoxazole |
| SMILES | C1CCNCC1.C1CCNCC1.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC(C)C.CC(C)C.CC(C)C.CC(C)C.CC(C)c1nc2ccccc2[nH]1.CC(C)c1nc2ccccc2o1.CC(C)c1nc2ccccc2s1.CC(C)n1nc2ccccc2n1.CC(C)n1nnc2ccccc21.c1ccc2[nH]ncc2c1.c1ccc2[nH]ncc2c1 |
| InChI | InChI=1S/C10H12N2.C10H11NO.C10H11NS.2C9H11N3.2C7H6N2.2C5H11N.4C4H10.17C2H6/c3*1-7(2)10-11-8-5-3-4-6-9(8)12-10;1-7(2)12-9-6-4-3-5-8(9)10-11-12;1-7(2)12-10-8-5-3-4-6-9(8)11-12;2*1-2-4-7-6(3-1)5-8-9-7;2*1-2-4-6-5-3-1;4*1-4(2)3;17*1-2/h3-7H,1-2H3,(H,11,12);4*3-7H,1-2H3;2*1-5H,(H,8,9);2*6H,1-5H2;4*4H,1-3H3;17*1-2H3 |
| InChIKey | HCHJFMZRORLBLE-UHFFFAOYSA-N |
| XLogP | 41.82 |
| TPSA | 210.44 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 140 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1971.38 |
| LogP ≤ 5 | 41.82 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158436560 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.